Follicular lymphoma: open trials in Sweden

• NCT06549595

  A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

  Trial Treatment · Phase 3 · AstraZeneca

  Falun · Uppsala

  Registry updated 2026-10-21

• NCT06526793

  Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

  Trial Treatment · Phase 2 · AstraZeneca

  Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Gothenburg · Karolinska University Hospital, Solna

  Registry updated 2026-10-14

• NCT05006716

  A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  Trial Treatment · Phase 1/2 · BeOne Medicines

  Sahlgrenska University Hospital Hematology, Gothenburg · Karolinska Universitetssjukhuset Solna, Stockholm

  Registry updated 2026-10-05

• 2023-508196-36-00

  Primary treatment of follicular lymphoma with rituximab-lenalidomide-tafasitamab for high-risk disease and rituximab-lenalidomide with a 1:1 randomization to tafasitamab for low-risk disease: a phase II study – NLG-FL7

  Trial Treatment · Phase 2 · Karolinska University Hospital

  Sahlgrenska University Hospital-Vastra Gotalandsregionen, Gothenburg · Laenssjukhuset I Kalmar Region Kalmar Laen, Kalmar · Region Skane Skanes Universitetssjukhus, Lund · Karolinska University Hospital, Solna · NU Hospital Group-Vastra Gotalandsregionen, Trollhattan · Norrlands University Hospital, Umeå · Uppsala University Hospital, Uppsala

  Registry updated 2026-06-16

• NCT04844866

  Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

  Trial Treatment · Phase 2 · Miltenyi Biomedicine GmbH

  Uppsala University Hospital, Uppsala

  Registry updated 2026-06-10

All Follicular lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error